Biolab announces the creation of its advisory board with Ana Karina Bortoni as chairman.
Biolab, one of the country's largest pharmaceutical companies, announces the restructuring of its governance model. One of the main changes is the arrival of experienced executive Ana Karina Bortoni as Chairman of the Independent Advisory Board. Ana Karina Bortoni, Chairman of the Advisory Board at Biolab FarmacêuticaWith a 25-year career, most of which at McKinsey & Company, Ana Karina led the development of Biolab's Corporate Governance project.
"Ana joins us with a focus on maintaining our continued healthy growth," explains Biolab CEO Cleiton de Castro Marques. "I am very honored to be part of this company that has been building a beautiful and solid history over the years. I've had the opportunity to work together with the partners in the past and now I'll have the pleasure of supporting their implementation," says Ana.